loader from loading.io

In the News, Oral insulin for T1D moves forward, T2D drug helps hearts, type 1 and teen brains and more

Diabetes Connections with Stacey Simms Type 1 Diabetes

Release Date: 09/02/2022

When your sibling has T1D: Stacey's daughter Lea shares her story show art When your sibling has T1D: Stacey's daughter Lea shares her story

Diabetes Connections with Stacey Simms Type 1 Diabetes

Stacey talks a lot about her son with type 1 but, as many of you know, she also has a daughter who doesn’t have diabetes. What’s it like to grow up with a sibling who gets more attention for something you can’t do anything about? Lea was five when her little brother was diagnosed – she’s now 21 and she has a lot to say. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible!

info_outline
In the News... Teplizumab approved, Twitter mess for Lilly, Medtronic 7-day infusion set launches, and more! show art In the News... Teplizumab approved, Twitter mess for Lilly, Medtronic 7-day infusion set launches, and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

It’s in the News.. the top diabetes stories of the past seven days. This week, the first drug to prevent T1D for any length of time is approved, Eli Lilly takes a financial hit from a Twitter impersonation stunt, Medtronic's 7-day pump infusion set is ready for consumers, Dexcom's G7 gets great reviews from older folks and educators for ease of use, a new study about light at night and diabetes and more! Learn more about the T1D Exchange: Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible!   Hello and welcome...

info_outline
The Future of Long-Term CGM Systems with Senseonics CMO Dr. Fran Kaufman show art The Future of Long-Term CGM Systems with Senseonics CMO Dr. Fran Kaufman

Diabetes Connections with Stacey Simms Type 1 Diabetes

Eversense is a CGM that goes under the skin and stays there for up to six months. The company that makes it has big plans to make that time period longer and to make the sensor even more accurate. Stacey talks to Senseonics Chief Medical Officer Dr. Francine Kaufman. They had a wide ranging conversation about everything from sensor length to interoperability and working with different pump systems as well as access and so much more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Episode Transcription Below (or...

info_outline
In the News.. Diabetes supply prices capped, New integrated insulin pen system, T1D diagnosis study and more! show art In the News.. Diabetes supply prices capped, New integrated insulin pen system, T1D diagnosis study and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

It's in the News.. the top diabetes stories of the past seven days. This week, one state caps not just insulin prices, but diabetes supplies for some, Lilly is out with a new integrated pen system, new study look at DKA at diagnosis of type 1 and what that means for health issues later on, and more! Learn more about the T1D Exchange: Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible!   Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines...

info_outline
Tips, Tricks and Building a Community: Meet Tom From Type One Talks show art Tips, Tricks and Building a Community: Meet Tom From Type One Talks

Diabetes Connections with Stacey Simms Type 1 Diabetes

Type One Talks is a popular YouTube channel with videos that help manage all sort of technology and situations around diabetes. But its host and founder says he wasn’t always that interested a diabetes deep dive. It all changed with his first CGM. Tom was an accountant in his former life so he really does love numbers. We’ll talk about his diagnosis as a child in the former Czechoslovakia, how much everything has changed and why he started making videos about diabetes technology, basically experimenting on himself. This podcast is not intended as medical advice. If you have those kinds of...

info_outline
In the News... Researching T2D drugs for T1D, Medtronic 780G moves ahead, Diabetes Awareness Month stuff and more! show art In the News... Researching T2D drugs for T1D, Medtronic 780G moves ahead, Diabetes Awareness Month stuff and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

It's in the News.. the top diabetes stories of the past seven days. This week: new research looks at off-label use of GLP and SGLT drugs for people with type 1, Medtronic gets 780G approval in Canada, finger prick early detection of type 1, and lots going on for Diabetes Awareness Month. Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. XX In the news is brought to...

info_outline
What are your What are your "Rules of Engagement?"- Conversations around CGM

Diabetes Connections with Stacey Simms Type 1 Diabetes

When it comes to using a CGM, the first question you may ask is, "How quickly can I get one?!" But this week, you'll hear there are a few other questions you may want to ask in order to get the most out of continuous glucose monitoring. In this excerpt from "Still the World's Worst Diabetes Mom: More Real Life Stories of Parenting a Child With Type 1 Diabetes," Stacey lays out conversations to have BEFORE you decide whether and how to use a CGM. Thinking this out can make your child’s use of a CGM more effective and with less stress for you. It may even be helpful for adults considering...

info_outline
Building Community Through Storytelling: SixUntilMe's Kerri Sparling show art Building Community Through Storytelling: SixUntilMe's Kerri Sparling

Diabetes Connections with Stacey Simms Type 1 Diabetes

The author of Kerri Sparling, isn’t blogging any more, but she’s still looking for stories of connection and community built around conversation For 14 years Kerri wrote a daily blog about her experience with type 1. She put aside SixUntilMe in 2019. We’re going to talk about what she thinks about the online community these days and what’s next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the...

info_outline
In the News... insulin rationing, DIY tech studies, iLet pump research and more! show art In the News... insulin rationing, DIY tech studies, iLet pump research and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

It’s It’s “In the News…” a look at the top diabetes stories and headlines of the past seven days. This week: a troubling new study about how many people with diabetes ration insulin, a new study looks at OpenAPS compared to traditional pumps, more research on Beta Bionics' iLet pump, an old diabetes drug might help in the fight against dementia, and more! Learn more about the T1D Exchange: https://t1dexchange.org/stacey/ Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! Hello and welcome to Diabetes...

info_outline
What happens at T1D teen retreats (and what adults can learn from them) show art What happens at T1D teen retreats (and what adults can learn from them)

Diabetes Connections with Stacey Simms Type 1 Diabetes

Who would volunteer to spend a weekend with a bunch of teens with type 1? A bunch of people who’ve been there! We’re talking about teen retreats – and what even adults can learn – about the power of connection. Patrick Mertes has lived with type 1 since he was a child. If that name sounds remember, he’s one of the climbers from the 50-in-50 project where he and a friend climbed the highest peak in all 50 states in 50 days a couple of years back. He also runs a fantastic family and teen retreat in North Carolina. This podcast is not intended as medical advice. If you have those kinds...

info_outline
 
More Episodes

It’s in the news! The top stories and headlines around the diabetes community this week include new progress in the quest for oral insulin to treat type 1, a new study says a common type 2 diabetes drug may help those with serious heart condition, a look at teen brains and T1D, NSAID and type 2 and more!

Learn about the T1d Exchange: www.t1dexchange.org/stacey 

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Episode Transcription Below (or coming soon!)

Please visit our Sponsors & Partners - they help make the show possible!

*Click here to learn more about OMNIPOD*

*Click here to learn more about AFREZZA*

*Click here to learn more about DEXCOM*

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.
XX
In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population.
https://t1dexchange.org/stacey/
XX
Our top story.. very early on here, but some progress in oral insulin for type 1. A team at University of British Columbia has developed a different kind of tablet that isn't made for swallowing, but instead dissolves when placed between the gum and cheek. This method delivered all the insulin to the liver without wasting or decomposing any insulin along the way. That’s a big change from earlier studies and methods. The oral tablets absorb after about half an hour and last for up to four hours.. long way to go, no human trials yet. The the lead researcher on this project has a father with type 1 .
https://www.sciencedaily.com/releases/2022/08/220830093215.htm?fbclid=IwAR1AzjI5UJma9I6g4hST044FS0MbJnUA0EXCmKXyhcOiOKL-ckIQTO4h8dY
XX
The type 2 diabetes drug dapagliflozin might also be used to help people with heart failure. A new study at Brigham and Women's Hospital showed that dapagliflozin – sold under the brand name Farxiga - reduced the risk of a cardiovascular death, or worsening heart failure, regardless of ejection fraction. Ejection fraction is a term that basically refers to how much blood is pumped out by the left ventricle of the heart each time it contracts. That’s important because this drug has already been shown to help people who have the reduced pumping. And that’s a lot more people. Big study here, more than 12-thousand people with lots of ages and races, benefits consistent throughout.
https://www.bostonglobe.com/2022/08/29/business/brigham-womens-researchers-say-diabetes-drug-helps-reduce-heart-failure/
XX
I hesitate to bring this study up, but it’s gotten a lot of attention this week. It shows tight control of blood sugar in teens with Type 1 diabetes may help reduce the disease’s damaging effects on the brain. But this small study from Nemours Children’s Health, Jacksonville and Stanford University School of Medicine didn’t release any numbers, n other words, it’s not clear what they mean by tight control or at what level they’re referring to for brain issues. Their findings to indicate that automated hybrid closed loop systems work really well and that better glucose control can actually improve brain structure and function in teens with type 1. I’ve reached out to this group and we’re working on getting more information in a future episode.
https://neurosciencenews.com/blood-sugar-brain-diabetes-21328/
XX
Very early on here.. but an Indiana startup says they have a potentially game changing type 1 drug in development. In T1D, the body’s immune system causes destruction of beta cells, and as a result, they eventually stop producing insulin. These researchers say their models show thy can take what were thought to be dead beta cells, which are actually sleeping beta cells, and increase their insulin secretion and, basically, get them back to a functional state.” They’re focusing on a calcium imbalance within the beta cell and designing molecules to correct that calcium imbalance, ultimately returning the pancreas to a healthy state. JDRF has given them a big grant for a two year project, hopefully getting them to clinical trials.
https://www.insideindianabusiness.com/articles/startup-awarded-nearly-1m-to-advance-diabetes-drug
XX
People with type 2 diabetes might face a substantially increased risk of heart failure if they take ibuprofen or some other type of nonsteroidal anti-inflammatory drug (NSAID), accord to a new Danish study.
Short-term NSAID use increased risk of hospitalization for heart failure by 43% in people with type 2 but no previous heart problems. This was a large but preliminary study presented at the European Society of Cardiology's annual meeting. NSAIDs increased the risk of heart failure even more in type 2 diabetics who were 80 or older (78%) or who had high blood sugar levels (68%), the results showed. Those who'd never used an NSAID before had the worst reaction, with their heart failure risk nearly tripling. Type 2 diabetics should consult with their doctor before taking any pain medicine, the doctors said. Other types of pain meds -- specifically acetaminophen (Tylenol) -- should be safe for them to use.
https://www.usnews.com/news/health-news/articles/2022-08-24/certain-painkillers-raise-heart-failure-risk-in-people-with-type-2-diabetes

XX
Back to the news in a moment but first..
The T1D Exchange Registry is a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. The platform is open to both adults and children with T1D living in the U.S. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. The registry aims to improve knowledge of T1D, accelerate the discovery and development of new treatments and technologies, and generate evidence to support policy or insurance changes that help the T1D community. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy.
The registry is now available on the T1D Exchange website and is simple to navigate, mobile and user-friendly. For more information or to register, go to www.t1dregistry.org/stacey
XX
We told you about The Human Trial, Watch this gripping new documentary about the brave men and women who volunteer to test a radical new treatment for type 1 diabetes. n 2011, Lisa Hepner and her husband Guy Mossman heard about a radical stem cell treatment for diabetes, a disease that shockingly kills more than five million people each year. Driven by a desire to cure Lisa of her own type 1 diabetes (T1D), the filmmakers were given unprecedented, real-time access to a clinical trial — only the sixth-ever embryonic stem cell trial in the world. What follows is an intimate journey with the patients and scientists who put themselves on the line to be first.
Now, in partnership with Beyond Type 1 & JDRF , they’re offering the film for free. You are urged to make a donation to JDRF when you click over, there is an option to select zero,
https://watch.showandtell.film/watch/the-human-trial-beyond-type-1
XX
Next week we’ve got a great episode all about Omnipod 5 in the real world. I spoke to a panel of moms and a young adult using the system. And we’ve got Insulet’s Director of Medical affairs addressing the questions that come up. This past episode is with my son Benny, talking about what it was like to spend 8 weeks away at non diabetes camp without any remote monitoring from us.
Listen wherever you get your podcasts
That’s In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.